Delivery Order SPE2DX15D8002-SPE2DX24F2VV4
Award Date
4/11/24
Potential Completion Date
4/12/24
Potential Value
$5.6K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,867.25 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,566,689,724 units of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which enables the company to provide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $13,666.77, is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceutical products. This delivery order contract does not have a set-aside designation. Dakota Drug, Inc. specializes in supplying a wide range of prescription medications, vaccines, medical devices, and other...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,665.26 contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceutical products to support military treatment facilities. This delivery order is issued against Dakota Drug's existing blanket purchase agreement and other contract vehicles...
This is a $10,142.13 firm fixed-price delivery order awarded on November 30, 2023 by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of 4562954307 DUPIXENT 300 MG/2 ML SYRINGE 2ML. The award has an ultimate completion date of December 1, 2023 and is not a set-aside contract. Dakota Drug, Inc. is a key pharmaceutical and medical supply vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) for the DLA...
The Defense Logistics Agency (DLA) awarded a $8,232.42 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML. This order was placed under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which supports the agency's ECAT Generation V Program for procuring commercial medical equipment, accessories, consumables, and simulation equipment. The contract has an...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $7,469.04, is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of February 13, 2024. The contract does not have a set-aside designation. Dakota Drug, Inc. has over two decades of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,070.96 firm fixed-price delivery order is for the pharmaceutical product DUPIXENT 300 mg/2 ml syringe, with a completion date of February 4, 2025. This order is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,881.32 contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a prescription pharmaceutical product, to support medical supply chain operations for the U.S. Armed Forces. The contract has a period of performance through May 30, 2024 and was awarded on May 29, 2024 without a set-aside designation,...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,390.56 firm fixed-price delivery order is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a completion date of February 13, 2024. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the Department of Defense and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,274.15 firm fixed-price delivery order is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a period of performance through February 1, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, as part of the ECAT Generation V Program, which allows the...